Prospective, Single Center, Pilot Study of Pretransplant Thymoglobulin Administration and Early Corticosteroid Withdrawal in Living Donor Renal Transplant Recipients Under Mycophenolate Mofetil (MMF) and Tacrolimus Immunosuppression

Trial Profile

Prospective, Single Center, Pilot Study of Pretransplant Thymoglobulin Administration and Early Corticosteroid Withdrawal in Living Donor Renal Transplant Recipients Under Mycophenolate Mofetil (MMF) and Tacrolimus Immunosuppression

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Corticosteroids; Mycophenolate mofetil; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Feb 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
    • 29 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 05 May 2010 Planned end date changed from 1 May 2009 to 1 Jul 2010 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top